Add like
Add dislike
Add to saved papers

Baseline Susceptibility of Spodoptera frugiperda (Lepidoptera: Noctuidae) to SfMNPV and Evaluation of Cross-Resistance to Major Insecticides and Bt Proteins.

The resistance evolution of Spodoptera frugiperda (J.E. Smith) to insecticides and Bt proteins along with the intensive crop production systems adopted in Brazil make it challenging to implement integrated pest management. The adoption of alternative methods to manage pests is fundamental to the implementation of favorable integrated pest management and insect resistance management. Spodoptera frugiperdamultiple nucleopolyhedrovirus (SfMNPV) is a valuable tool for S. frugiperda control. The characterization of the baseline susceptibility of S. frugiperda populations and cross-resistance involving SfMNPV and major insecticides and Bt proteins have not yet been conducted. The objective of this study was to characterize the baseline susceptibility of S. frugiperda populations from five Brazilian States to SfMNPV (Cartugen, AgBiTech, Fort Worth, TX). Possible cross-resistance to insecticides and Bt proteins among resistant S. frugiperda strains was also assessed. There were no differences in the susceptibility of the studied populations to SfMNPV. The estimated diagnostic concentration may be utilized in future monitoring studies to SfMNPV. The SfMNPV presented no cross-resistance to the chemical insecticides and to the Bt proteins tested. Our results provide evidence of the biological activity and high potential of SfMNPV as a distinct insecticidal mode of action for use in rotation with other tools. This biological insecticide is known to have a favorable toxicological and ecotoxicological profile and will be a valuable tool in insect resistance management and integrated pest management programs for control of S. frugiperda.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app